Serum zinc and copper in active rheumatoid arthritis: Correlation with interleukin 1? and tumour necrosis factor ?

A. Zoli; L. Altomonte; R. Caricchio; A. Galossi; L. Mirone; M. P. Ruffini; M. Magar�

doi:10.1007/bf01450895

Serum zinc and copper in active rheumatoid arthritis: Correlation with interleukin 1? and tumour necrosis factor ?

Clinical Rheumatology ◽

10.1007/bf01450895 ◽

1998 ◽

Vol 17 (5) ◽

pp. 378-382 ◽

Cited By ~ 61

Author(s):

A. Zoli ◽

L. Altomonte ◽

R. Caricchio ◽

A. Galossi ◽

L. Mirone ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Interleukin 1 ◽

Serum Zinc ◽

Necrosis Factor

Download Full-text

Ceramide, a mediator of interleukin 1, tumour necrosis factor alpha , as well as Fas receptor signalling, induces apoptosis of rheumatoid arthritis synovial cells

Annals of the Rheumatic Diseases ◽

10.1136/ard.57.8.495 ◽

1998 ◽

Vol 57 (8) ◽

pp. 495-499 ◽

Cited By ~ 16

Author(s):

N. Mizushima ◽

H. Kohsaka ◽

N. Miyasaka

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Interleukin 1 ◽

Tumour Necrosis Factor Alpha ◽

Synovial Cells ◽

Necrosis Factor Alpha ◽

Receptor Signalling ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

The Lancet ◽

10.1016/s0140-6736(12)61424-x ◽

2013 ◽

Vol 381 (9865) ◽

pp. 451-460 ◽

Cited By ~ 393

Author(s):

Gerd R Burmester ◽

Ricardo Blanco ◽

Christina Charles-Schoeman ◽

Jürgen Wollenhaupt ◽

Cristiano Zerbini ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Inadequate Response ◽

Phase 3 ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2011-200956 ◽

2012 ◽

Vol 71 (10) ◽

pp. 1671-1679 ◽

Cited By ~ 38

Author(s):

Josef S Smolen ◽

Jonathan Kay ◽

Robert B M Landewé ◽

Eric L Matteson ◽

Norman Gaylis ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Previous Experience ◽

Double Blind ◽

Double Blind Placebo ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy

Annals of the Rheumatic Diseases ◽

10.1136/ard.2006.066605 ◽

2007 ◽

Vol 66 (10) ◽

pp. 1284-1288 ◽

Cited By ~ 67

Author(s):

J. Grisar ◽

D. Aletaha ◽

C. W Steiner ◽

T. Kapral ◽

S. Steiner ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Progenitor Cells ◽

Endothelial Progenitor Cells ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Glucocorticoid Therapy ◽

Endothelial Progenitor ◽

Necrosis Factor

Download Full-text

Tumour necrosis factor blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study

Annals of the Rheumatic Diseases ◽

10.1136/ard.2009.119412 ◽

2009 ◽

Vol 69 (7) ◽

pp. 1281-1285 ◽

Cited By ~ 43

Author(s):

M. J. L. Peters ◽

P. Welsh ◽

I. B. McInnes ◽

G. Wolbink ◽

B. A. C. Dijkmans ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Cohort Study ◽

Brain Natriuretic Peptide ◽

Tumour Necrosis Factor ◽

Natriuretic Peptide ◽

Prospective Cohort Study ◽

Prospective Cohort ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Necrosis Factor

Download Full-text

Effects of tumour necrosis factor alpha blockade on lipid profile in active rheumatoid arthritis

Rheumatology ◽

10.1093/rheumatology/kem195 ◽

2007 ◽

Vol 46 (10) ◽

pp. 1626-1627 ◽

Cited By ~ 6

Author(s):

F. Del Porto ◽

B. Lagana ◽

I. Nofroni ◽

F. Tinti ◽

A. P. Mitterhofer ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Lipid Profile ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Tumour Necrosis Factor Alpha ◽

Necrosis Factor Alpha ◽

Alpha Blockade ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

SAT0115 Tofacitinib Versus Biologic Treatments in Patients with Active Rheumatoid Arthritis Who have had an Inadequate Response to Tumour Necrosis Factor Inhibitors - A Network Meta-Analysis

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.1841 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A619.3-A620 ◽

Cited By ~ 1

Author(s):

M. C. Vieira ◽

G. Wallenstein ◽

J. Bradley ◽

D. Gruben ◽

T. Koncz ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Inadequate Response ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor , interleukin 1, and receptor activator of nuclear factor B ligand (RANKL) regulate osteoclasts

Annals of the Rheumatic Diseases ◽

10.1136/ard.2003.008458 ◽

2004 ◽

Vol 63 (4) ◽

pp. 354-359 ◽

Cited By ~ 84

Author(s):

D O' Gradaigh

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Interleukin 1 ◽

Nuclear Factor ◽

Factor B ◽

Receptor Activator ◽

Necrosis Factor ◽

Joint Erosion

Download Full-text

Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-203435 ◽

2013 ◽

Vol 73 (10) ◽

pp. 1811-1818 ◽

Cited By ~ 21

Author(s):

Josef S Smolen ◽

Jonathan Kay ◽

Eric L Matteson ◽

Robert Landewé ◽

Elizabeth C Hsia ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Factor Therapy ◽

Post Hoc ◽

Necrosis Factor

Download Full-text

Faculty Opinions recommendation of The efficacy of inhibiting tumour necrosis factor alpha and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisons.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13284967.14644067 ◽

2011 ◽

Author(s):

Claudia Sommer

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Meta Analysis ◽

Interleukin 1 ◽

Tumour Necrosis Factor Alpha ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Indirect Comparisons ◽

Necrosis Factor

Download Full-text